Regulation of Proteolytic Activity in Tissues

References

• Hazuda D. J., Strickler J., Kueppers F., Simon P. L., Young P. R. Processing of precursor interleukin 1 beta and inflammatory disease. J. Biol. Chem. 1990; 265: 6318
   PubMed Web of Science ®Google Scholar
• Rosser B. G., Powers S. P., Gores G. J. Calpain activity increases in hepatocytes following addition of ATP. J. Biol. Chem. 1993; 268: 23593
   PubMedGoogle Scholar
• Rivett A. J. Proteasomes. Multicatalytic proteinase complexes. Biochem. J. 1993; 291: 1
   PubMed Web of Science ®Google Scholar
• Cierchanover A., Schwartz A. L. The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J. 1994; 8: 182
   Google Scholar
• Finley D., Chau V. Ubiquination. Annu. Rev. Cell Biol. 1991; 7: 25
   PubMedGoogle Scholar
• Woessner J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145
   PubMed Web of Science ®Google Scholar
• Hirschi K. K., Vasiloudes P., Brannon P. M. Effects of secretin and caerulein on pancreatic digestive enzymes in cultured rat acinar cells. Pancreas 1994; 9: 91
   Google Scholar
• Scott G. K. Proteinases and proteinase inhibitors as modulators of animal cell growth. Comp. Biochem. Physiol. B 1992; 103: 785
   Google Scholar
• Hembry R. M., Bagga M. R., Murphy G., Henderson B., Reynolds J. J. Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am. J. Pathol. 1993; 143: 628
   Google Scholar
• Genever P. G., Wood E. J., Cunliffe W. J. Fibroblast-keratinocyte interactions: influence on collagenase activity in wound healing models. Biochem. Soc. Trans. 1992; 20: 373S
   Google Scholar
• Agren M. S., Taplin C. J., Woessner J. F., Jr., Eaglstein W. H., Mertz P. M. Collagenase in wound healing: effect of wound age and type. Journal of Investigative Dermatology 1992; 99: 709
   PubMed Web of Science ®Google Scholar
• Girard M. T., Matsubara M., Kublin C., Tessier M. J., Cintron C., Fini M. E. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J. Cell Sci. 1993; 104: 1101
   PubMedGoogle Scholar
• Mann K. G., Jenny R. J., Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu. Rev. Biochem. 1988; 57: 915
   PubMed Web of Science ®Google Scholar
• Collen D., Lijnen H. R. Fibrin-specific fibrinolysis. Ann. N.Y. Acad. Sci. 1992; 667: 259
   Google Scholar
• Sim R. B., Kolble K., McAleer M. A., Dominguez O., Dee V. M. Genetics and deficiencies of the soluble regulatory proteins of the complement system. Int. Rev. Immunol. 1993; 10: 65
   PubMedGoogle Scholar
• Neurath H. The versatility of proteolytic enzymes. J. Cell. Biochem. 1986; 32: 35
   PubMed Web of Science ®Google Scholar
• Sasaki M., Kunimatsu M., Tada T., Nishimura J., Ma X. J., Ohkubo I. Calpain and kininogen mediated inflammation. Biomed. Biochim. Acta 1991; 50: 499
   Google Scholar
• Matrisian L. M., Hogan B. L. M. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Develop. Biol. 1990; 24: 219
   PubMedGoogle Scholar
• Werb Z., Alexander C. M., Adler R. R. Expression and function of matrix metalloproteinases in development. Matrix Suppl. 1992; 1: 337
   PubMedGoogle Scholar
• Hamilton R. T., Bruns K. A., Delgado M. A., Shim J. K., Fang Y., Denhardt D. T., Nilsen-Hamilton M. Developmental expression of cathespin L and c-rasHa in the mouse placenta. Molecular Reproduction & Development 1991; 30: 285
   PubMed Web of Science ®Google Scholar
• Niedbaia M. J. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Act.—Suppl. 1993; 42: 179
   Google Scholar
• Rechberger T., Woessner J. F. Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am. J. Obstet. Gynecol. 1993; 168: 1598
   Google Scholar
• Talhouk R. S., Bissell M. J., Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell. Biol. 1992; 118: 1271
   PubMed Web of Science ®Google Scholar
• Cunningham D. D. Regulation of neuronal cells and astrocytes by protease nexin-1 and thrombin. Ann. New York Acad. Aci. 1992; 674: 228
   Google Scholar
• Fridman R., Bird R. E., Hoyhtya M., Oelkuct M., Komarek D., Liang C. M., Berman M. L., Liotta L. A., Stetler-Stevenson W. G., Fuerst T. R. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metallo-proteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem. J. 1993; 289: 411
   Google Scholar
• Scott G. K., Tse C. A. Growth-related proteinases in cultured human tumour cells. Biol. Chem. Hoppe-Seyler 1992; 373: 605
   Google Scholar
• Schuster M. G., Enriquez P. M., Curran P., Cooperman B. S., Rubin H. Regulation of neutrophil superoxide by anti-chymotrypsin-chymotrypsin complexes. J. Biol. Chem. 1992; 267: 5056
   PubMed Web of Science ®Google Scholar
• Evans C. H. The role of proteinases in cartilage destruction. Agents Actions Suppl. 1991; 32: 135
   Google Scholar
• Katunuma N. New biological functions of intracellular proteases and their endogenous inhibitors as bioreactants. Adv. Enzyme Regul. 1990; 30: 377
   Google Scholar
• Laslop A., Fischer-Colbrie R., Kirschke H., Hogue-Angeletti R., Winkler H. Chromogranin A-processing proteinases in purified chromaffin granules: contaminants or endogenous enzymes. Biochim. Biophys. Acta 1990; 1033: 65
   Google Scholar
• Stracke M. L., Liotta L. A. Multi-step cascade of tumor cell metastasis. In Vivo 1992; 6: 309
   PubMedGoogle Scholar
• Zhang J. Y., Schultz R. M. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Cancer Res. 1992; 52: 6682
   Google Scholar
• Trabandt A., Gay R. E., Fassbender H. G., Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arth. Rheum. 1991; 34: 1444
   PubMedGoogle Scholar
• Dalbey R. E., von Heinje G. Signal peptidases in prokaryotes and eukaryotes — a new protease family. Trends Biol. Sci. 1992; 17: 474
   PubMed Web of Science ®Google Scholar
• Rechsteiner M., Hoffman L., Dubiel W. The multicatalytic and 26 S proteases. J. Biol. Chem. 1993; 268: 6065
   PubMed Web of Science ®Google Scholar
• Rawlings N. D., Barrett A. J. Evolutionary families of peptides. Biochem. J. 1993; 290: 205
   PubMed Web of Science ®Google Scholar
• Kwaan H. C. The biologic role of components of the plasminogen-plasmin system. Prog. Cardiovasc. Dis. 1992; 34: 309
   Google Scholar
• Kido H., Fukutomi A., Katunuma N. A novel membrane-bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gpl20 of HIV-1. Biomed. Biochim. Acta 1991; 50: 781
   Google Scholar
• Trapani J. A., Smyth M. J. Killing of cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation (review). Immun. Cell Biol. 1993; 71: 201
   Google Scholar
• Burkhardt J. K., Hester S., Lapham C. K., Argon Y. The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J. Cell Biol. 1990; 111: 2327
   Google Scholar
• Salvesen G., Enghild J. J. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases. Biomed. Biochim. Acta 1991; 50: 665
   Google Scholar
• Powers J. C., Odake S., Oleksyszyn J., Hori H., Ueda T., Boduszek B., Kam C. Proteases — structures, mechanism and inhibitors. Agents Act. — Suppl. 1993; 42: 3
   PubMedGoogle Scholar
• Dunn B. M. Determination of protease mechanism. Proteolytic Enzymes: A practical approach, R. J. Beynon, J. S. Bond. IRL Press. 1989; 57–81
   Google Scholar
• Lolis E., Petsko G. A. Transition-state analogues in protein crystallography: Probes of the structural source of enzyme catalysis. Ann. Rev. Biochem. 1990; 59: 597
   Google Scholar
• Chen L., Mao S. J., Larsen W. J. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J. Biol. Chem. 1992; 267: 12380
   PubMedGoogle Scholar
• Bloomquist B. T., Mains R. E. The eukaryotic prohormone-processing endo-proteases. Cell. Phys. Biochem. 1993; 3: 197
   Google Scholar
• Halban P. A., Irminger J.-I. Sorting and processing of secretory proteins. Biochem. J. 1994; 299: 1
   PubMedGoogle Scholar
• Steiner D. F., Smeekens S. P., Ohagi S., Chan S. J. The new enzymology of precursor processing endoproteases. J. Biol. Chem. 1992; 267: 23435
   PubMedGoogle Scholar
• Qian F., Chan S. J., Gong Q. M., Bajkowski A. S., Steiner D. F., Frankfater A. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors. Biomed. Biochim. Acta 1991; 50: 531
   Google Scholar
• Nishimura Y., Kawabata T., Yano S., Kato K. Inhibition of intracellular sorting and processing of lysosomal cathepsins H and L at reduced temperature in primary cultures of rat hepatocytes. Arch. Biochem. Biophys. 1990; 283: 458
   Google Scholar
• Furuhashi M., Nakahara A., Fukutomi H., Kominami E., Grube D., Uchiyama Y. Immunocytochemical localization of cathepsins B, H, and L in the rat gastroduodenal mucosa. Histochemistry 1991; 95: 231
   Google Scholar
• Saito A., Sinohara H. Rabbit plasma α-1-antiproteinase s-1 — cloning, sequencing, expression and proteinase inhibitory properties of recombinant protein. J. Biochem. 1993; 113: 456
   Google Scholar
• Lah T. T., Babnik J., Schiffmann E., Turk V., Skaleric U. Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. Journal of Periodontology 1993; 64: 485
   Google Scholar
• Goll D. E., Thompson V. F., Taylor R. G., Christiansen J. A. Role of the calpain system in muscle growth. Biochimie 1992; 74: 225
   PubMed Web of Science ®Google Scholar
• Suzuki K., Saido T. C., Hirai S. Modulation of cellular signals by calpain. Ann. N.Y. Acad. Sci. 1992; 674: 218
   PubMed Web of Science ®Google Scholar
• Melloni E., Salamino F., Sparatore B. The calpain-calpastatin system in mammalian cells: properties and possible functions. Biochimie 1992; 74: 217
   PubMedGoogle Scholar
• Saido T., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 1994; 8: 814
   PubMed Web of Science ®Google Scholar
• Taylor R. G., Christiansen J. A., Goll D. E. Immunolocalization of the calpains and calpastatin in human and bovine platelets. Biomed. Biochim. Acta 1991; 50: 491
   Google Scholar
• Shimizu K., Hamamoto T., Hamakubo T., Lee W. J., Suzuki K., Nakagawa Y., Murachi T., Yamamuro T. Immunohistochemical and biochemical demonstration of calcium-dependent cysteine proteinase (calpain) in calcifying cartilage of rats. J. Orthopaed. Res. 1991; 9: 26
   PubMed Web of Science ®Google Scholar
• Sorimachi H., Suzuki K. Sequence comparison among muscle-specific calpain, p94, and calpain subunits. Biochim. Biophys. Acta 1992; 1160: 55
   Google Scholar
• Litersky J. M., Johnson G. V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 1992; 267: 1563
   PubMed Web of Science ®Google Scholar
• Friedrich P., Aszodi A. MAP2: a sensitive cross-linker and adjustable spacer in dendritic architecture. FEBS Lett. 1991; 295: 5
   Google Scholar
• Johnson G. V., Foley V. G. Calpainmediated proteolysis of microtubule-associated protein 2 (MAP-2) is inhibited by phosphorylation by cAMP-dependent protein kinase, but not by Ca2+/calmodulin-dependent protein kinase II. J. Neurosci. Res. 1993; 34: 642
   PubMedGoogle Scholar
• Hirai S., Kawasaki H., Yaniv M., Suzuki K. Degradation of transcription factors, c-jun and c-fos, by calpain. FEBS Lett. 1991; 287: 57
   PubMed Web of Science ®Google Scholar
• Edwards D. R., Rocheleau H., Sharma R. R., Wills A. J., Cowie A., Hassell J. A., Heath J. K. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1992; 1171: 41
   PubMedGoogle Scholar
• Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768
   PubMed Web of Science ®Google Scholar
• Bode W., Engh R., Musil D., Laber B., Stubbs M., Huber R., Turk V. Mechanism of interaction of cysteine proteinases and their protein inhibitors as compared to the serine proteinase-inhibitor interaction. Biol. Chem. Hoppe-Seyler 1990; 371(Suppl)111
   Google Scholar
• Hasnain S., Huber C. P., Muir A., Rowan A. D., Mort J. S. Investigation of structure function relationships in cathepsin B. Biol. Chem. Hoppe-Seyler 1992; 373: 413
   Google Scholar
• Barrett A. J. Cellular proteolysis. An overview. Ann. New York Acad. Sci. 1992; 674: 1
   Google Scholar
• Girard M. T., Matsubara M., Kublin C., Tessier M. J., Cintron C., Fini M. E. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J. Cell Sci. 1993; 104: 1001
   PubMed Web of Science ®Google Scholar
• Fini M. E., Girard M. T. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1779
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E. Extracellular matrix-6. Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993; 7: 1434
   PubMed Web of Science ®Google Scholar
• Monsky W. L., Kelly T., Lin C. Y., Yeh Y., Stetler-Stevenson W. G., Mueller S. C., Chen W. T. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res. 1993; 53: 3159
   PubMed Web of Science ®Google Scholar
• Lovejoy B., Cleasby A., Hassell A. M., Inogley K., Luther M. A., Weigl D., McGeehan G., McElroy A. B., Drewry D., Lambert M. H., Jordan S. R. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 1994; 263: 375
   PubMed Web of Science ®Google Scholar
• Gooley P. R., O'Connell J. F., Marcy A. I., Cuca G. C., Salowe S. P., Bush B. L., Hermes J. D., Esser C. K., Hagmann W. K., Springer J. P., Johnson B. A. The NMR structure of the inhibited catalytic domain of human stromelysin-1. Nature Str. Biol. 1994; 1: 111
   PubMedGoogle Scholar
• Salowe S. P., Marcy A. I., Cuca G. C., Smith C. K., Kopka I. E., Hagmann W. K., Hermes J. D. Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme. Biochemistry 1992; 31: 5578
   Google Scholar
• Kay J., Dunn B. M. Substrate specificity and inhibitors of aspartic proteinases (review). Scand. J. Clin. Lab. Invest. Supp. 1992; 210: 23
   Google Scholar
• Yonezawa S., Maejima Y., Hagiwara N., Aratani T., Shoji R., Kageyama T., Tsukada S., Miki K., Ichinose M. Changes with development in the expression of cathepsin-E in the fetal rat stomach. Dev. Growth Differ. 1993; 35: 349
   Google Scholar
• Yonezawa S., Fujii K., Maejima Y., Tamoto K., Mori Y., Muto N. Further studies on rat cathepsin E: subcellular localization and existence of the active subunit form. Arch. Biochem. Biophys. 1988; 267: 176
   Google Scholar
• Saku T., Sakai H., Tsuda N., Okabe H., Kato Y., Yamamoto K. Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. Gut 1990; 31: 1250
   PubMedGoogle Scholar
• Rodman J. S., Levy M. A., Diment S., Stahl P. D. Immunolocalization of endosomal cathepsin D in rabbit alveolar macrophages. J. Leukocyte Biol. 1990; 48: 116
   Google Scholar
• Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Ann. Rev. Biochem. 1992; 61: 307
   PubMed Web of Science ®Google Scholar
• Szecsi P. B. The aspartic proteases. Scand. J. Clin. Lab. Invest. Suppl. 1992; 210: 5
   PubMedGoogle Scholar
• Sielecki A. R., Fedorov A. A., Boodhoo A., Andreeva N. S., James M. N. G. Molecular and crystal structure of monoclinic porcine pepsin refined at 1.8 A resolution. J. Mol. Biol. 1990; 214: 143
   PubMed Web of Science ®Google Scholar
• Lin X. L., Fusek M., Chen Z., Koelsch G., Han H. P., Hartsuck J. A., Tang J. Studies on pepsin mutagenesis and recombinant Rhizopuspepsinogen. Adv. Exp. Med. Biol. 1992; 306: 1
   Google Scholar
• Rhaissi H., Bechet D., Ferrara M. Multiple leader sequences for mouse cathepsin-B messenger. Biochimie 1993; 75: 899
   Web of Science ®Google Scholar
• Moshier J. A., Cornell T., Majumdar A. P. N. Expression of protease genes in the gastric mucosa during aging. Exp. Gerontol. 1993; 28: 249
   PubMed Web of Science ®Google Scholar
• Hurwitz A., Dushnik M., Solomon H., Ben-Chetrit A., Finci-Yeheskel Z., Milwidsky A., Mayer M., Adashi E. Y., Yagel S. Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase. Endocrinology 1993; 132: 2709
   Google Scholar
• Stricklin G. P., Li L. Y., Jancic V., Wenczak B. A., Nanney L. B. Localization of messenger RNAs representing collagenase and TIMP in sections of healing human burn wounds. Am. J. Pathol. 1993; 143: 1657
   Google Scholar
• Gerritsen M. E., Bloor C. M. Endothelial cell gene expression in response to injury. FASEB J. 1993; 7: 523
   PubMed Web of Science ®Google Scholar
• James T. W., Wagner R., White L. A., Zwolak R. M., Brinckerhoff C. E. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J. Cell. Physiol. 1993; 157: 426
   PubMed Web of Science ®Google Scholar
• Agarwal C., Hembree J. R., Rorke E. A., Eckert R. L. Transforming growth factor β-1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res. 1994; 54: 943
   PubMedGoogle Scholar
• Wolf C., Rouyer N., Lutz Y., Adida C., Loriot M., Bellocq J. P., Chambon P., Basset P. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 1843
   PubMed Web of Science ®Google Scholar
• Emonard H., Christiane Y., Smet M., Grimaud J. A., Foidart J. M. Type IV and interstitial collagenolytic activities in normal and malignant trophoblast cells are specifically regulated by the extracellular matrix. Invasion & Metastasis 1990; 10: 170
   PubMedGoogle Scholar
• Collier I. E., Wilhelm S. M., Eisen A. Z., Marmer B. L., Grant G. A., Seltzer J. L., Kronberger A., He C., Bauer E. A., Goldberg G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 1988; 263: 6579
   PubMed Web of Science ®Google Scholar
• Mohtai M., Smith R. L., Schurman D. J., Tsuji Y., Torti F. M., Hutchinson N. I., Stetler-Stevenson W. G., Goldberg G. I. Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J. Clin. Invest. 1993; 92: 179
   PubMed Web of Science ®Google Scholar
• Wolfe G. C., MacNaul K. L., Buechel F. F., McDonnell J., Hoerrner L. A., Lark M. W., Moore V. L., Hutchinson N. I. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin osteoarthritis patients and in 2 animal models of acute inflammatory arthritis. Arthritis Rheum. 1993; 36: 1540
   PubMedGoogle Scholar
• Petanceska S., Devi L. Sequence analysis, tissue distribution, and expression of rat cathepsin S. J. Biol Chem. 1992; 267: 26038
   PubMed Web of Science ®Google Scholar
• Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 1992; 31: 125
   PubMed Web of Science ®Google Scholar
• Foucre D., Bouchet C., Hacene K., Pourreau-Schneider N., Gentile A., Martin P. M., Desplaces A., Oglobine J. Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours. Br. J. Cancer 1991; 64: 926
   PubMed Web of Science ®Google Scholar
• Chauhan S. S., Goldstein L. J., Gottesman M. M. Expression of cathepsin L in human tumors. Cancer Res. 1991; 51: 1478
   PubMed Web of Science ®Google Scholar
• Buck M. R., Karustis D. G., Day N. A., Honn K. V., Sloane B. F. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 1992; 282: 273
   PubMedGoogle Scholar
• McDonnell S., Fingleton B. Role of matrix metalloproteinases in invasion and metastasis — biology, diagnosis and inhibitors. Cytotechnology 1993; 12: 367
   Google Scholar
• Garcia M., Derocq D., Pujol P., Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990; 5: 1809
   PubMed Web of Science ®Google Scholar
• Sanchez L. M., Freije J. P., Merino A. M., Vizoso F., Foltmann B., Lopez-Otin C. Isolation and characterization of a pepsin C zymogen produced by human breast tissues. J. Biol. Chem. 1992; 267: 24725
   Google Scholar
• Majmudar G., Nelson B. R., Jensen T. C., Voorhees J. J., Johnson T. M. Increased expression of stromelysin-3 in basal cell carcinomas. Mol. Carcinogen. 1994; 9: 17
   PubMedGoogle Scholar
• Kawami Y., Yoshida K., Ohsaki A., Kuroi K., Nishiyama M., Toge T. Stromelysin-3 mRNA expression and malignancy. Comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors. Anticancer Res. 1993; 13: 2319
   Google Scholar
• Fini M. E., Girard M. T. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1779
   PubMed Web of Science ®Google Scholar
• published erratum appears in Invest. Ophthalmol. Vis. Sci. 1990; 31(11)2229
   Google Scholar
• Cavailles V., Augereau P., Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 203
   PubMed Web of Science ®Google Scholar
• May F. E., Smith D. J., Westley B. R. The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene 1993; 134: 277
   PubMedGoogle Scholar
• Samples J. R., Alexander J. P., Acott T. S. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest. Ophthalmol. Vis. Sci. 1993; 34: 3386
   PubMed Web of Science ®Google Scholar
• Lyons J. G., Birkedalhansen B., Pierson M. C., Whitelock J. M., Birkedalhansen H. Interleukin-1-β growth factor-α epidermal growth factor induce expression of Mr95,000 type-IV collagenase gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J. Biol. Chem. 1993; 268(19)143
   Google Scholar
• Hamilton J. A., Piccoli D. S., Leizer T., Butler D. M., Croatto M., Royston A. K. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 7180
   Google Scholar
• Martel-Pelletier J., Zafarullah M., Kodama S., Pelletier J. P. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J. Rheumatol., Suppl. 1991; 27: 80
   Google Scholar
• Mauviel A., Chen Y. Q., Dong W., Evans C. H., Uitto J. Transcriptional interactions of transforming growth-factor-beta with pro-inflation cytokines. Curr. Biol. 1993; 3: 822
   Google Scholar
• Keski-Oja J., Koli K., Lohi J., Laiho M. Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Semin. Thromb. Hemost. 1991; 17: 231
   PubMed Web of Science ®Google Scholar
• Vanbennekum A. M., Emeis J. J., Kooistra T., Hendriks H. F. J. Modulation of tissue-type plasminogen activator by retinoids in rat plasma and tissues. Am. J. Physiol. 1993; 264: R931
   Google Scholar
• Thompson E. A., Nelles L., Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur. J. Biochem. 1991; 201: 627
   Google Scholar
• Kooistra T., Opdenberg J. P., Toet K., Hendriks H. F., van den Hoogen R. M., Emeis J. J. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb. Haemost. 1991; 65: 565
   PubMed Web of Science ®Google Scholar
• Wojta J., Zoellner H., Gallicchio M., Hamilton J. A., McGrath K. Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem. Biophys. Res. Commun. 1992; 188: 463
   Google Scholar
• Ito A., Itoh Y., Sasaguri Y., Morimatsu M., Mori Y. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum. 1992; 35: 1197
   PubMedGoogle Scholar
• Shi G. Y., Hau J. S., Wang S. J., Wu I. S., Chang B. I., Lin M. T., Chow Y. H., Chang W. C., Wing L. Y., Jen C. J., et al. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells. J. Biol. Chem. 1992; 267: 19363
   Google Scholar
• Hayakawa Y., Tazawa S., Ishikawa T., Niiya K., Sakuragawa N. Thrombin regulation of tissue-type plasminogen activator synthesis in cultured human fetal lung fibroblasts. Thromb. Res. 1993; 71: 457
   Google Scholar
• Ciambrone G. J., McKeown-Longo P. J. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J. Biol. Chem. 1992; 267: 13617
   PubMed Web of Science ®Google Scholar
• Shapiro S. D., Kobayashi D. K., Pentland A. P., Welgus H. G. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substratespecific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 1993; 268: 8170
   PubMed Web of Science ®Google Scholar
• Tremble P. M., Lane T. F., Sage E. H., Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metallo-proteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J. Cell Biol. 1993; 121: 1433
   PubMed Web of Science ®Google Scholar
• Frixen U. H., Nagamine Y. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res. 1993; 53: 3618
   Google Scholar
• Scharffetter-Kochanek K., Wlaschek M., Briviba K., Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett. 1993; 331: 304
   PubMed Web of Science ®Google Scholar
• McCarthy G. M., Mitchell P. G., Struve J. A., Cheung H. S. Basic calcium phosphate crystals cause coordinate induction and secretion of collagenase and stromelysin. J. Cell. Physiol. 1992; 153: 140
   PubMed Web of Science ®Google Scholar
• Takahashi S., Sato T., Ito A., Ojima Y., Hosono T., Nagase H., Mori Y. Involvement of protein kinase-C in the interleukin-1 α induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human cervical fibroblasts. Biochim. Biophys. Acta 1993; 1220: 57
   PubMed Web of Science ®Google Scholar
• Ohlsson M., Peng X.-R., Liu Y.-X., Jia X.-C., Hsueh A. J. W., Ny T. Hormone regulation of tissue-type plasminogen activator gene expression and plasminogen activator-mediated proteolysis. Semin. Thromb. Hemost. 1991; 17: 286
   Google Scholar
• Saksela O., Rifkin D. B. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 1988; 4: 93
   PubMedGoogle Scholar
• Delany A. M., Brinckerhoff C. E. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J. Cell. Biochem. 1992; 50: 400
   PubMed Web of Science ®Google Scholar
• Krane S. M. Some molecular mechanisms of glucocorticoid action. Br. J. Rheumatol. 1993; 32(Suppl. 2)3
   Google Scholar
• Qian F., Frankfater A., Chan S. J., Steiner D. F. The structure of the mouse cathepsin B gene and its putative promoter. DNA Cell Biol. 1991; 10: 159
   PubMedGoogle Scholar
• Redecker B., Heckendorf B., Grosch H. W., Mersmann G., Hasilik A. Molecular organization of the human cathepsin D gene. DNA Cell Biol. 1991; 10: 423
   PubMed Web of Science ®Google Scholar
• Ishidoh K., Suzuki K., Katunuma N., Kominami E. Gene structures of rat cathepsins H and L. Biomed. Biochim. Acta 1991; 50: 541
   Google Scholar
• Rochefort H. Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the matastatic process. Comp. Ren. Seanc. Soc. Biol. Ses Fil. 1991; 185: 415
   Google Scholar
• Sato H., Kita M., Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 1993; 268(23)560
   Google Scholar
• Murphy P. G., Hart D. A. Regulation of plasminogen activator and plasminogen activator inhibitor expression by cells of neural origin. Semin. Thromb. Hemost. 1991; 17: 268
   Google Scholar
• Brinckerhoff C. E., Sirum-Connolly K. L., Karmilowicz M. J., Auble D. T. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts. Matrix Suppl 1992; 1: 165
   Google Scholar
• Lafyatis R., Kim S. J., Angel P., Roberts A. B., Sporn M. B., Karin M., Wilder R. L. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol. Endocrinol. 1990; 4: 973
   PubMed Web of Science ®Google Scholar
• Pan L., Chamberlain S. H., Auble D. T., Brinckerhoff C. E. Differential regulation of collagenase gene expression by retinoic acid receptors-alpha, beta and gamma. Nucleic Acids Res. 1992; 20: 3105
   PubMed Web of Science ®Google Scholar
• Gong Q., Chan S. J., Bajkowski A. S., Steiner D. F., Frankfater A. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol. 1993; 12: 299
   PubMed Web of Science ®Google Scholar
• Chauhan S. S., Popescu N. C., Ray D., Fleischmann R., Gottesman M. M., Troen B. R. Cloning, genomic organization, and chromosomal localization of human cathepsin L. J. Biol. Chem. 1993; 268: 1039
   PubMedGoogle Scholar
• Azuma T., Liu W. G., Vander Laan D. J., Bowcock A. M., Taggart R. T. Human gastric cathepsin E gene. Multiple transcripts result from alternative polyadenylation of the primary transcripts of a single gene locus at 1q31-q32. J. Biol. Chem. 1992; 267: 1609
   Google Scholar
• Lee W. J., Ma H., Takano E., Yang H Q., Hatanaka M., Maki M. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 1992; 267: 8437
   PubMed Web of Science ®Google Scholar
• Moll S., Schifferli J. A., Huarte J., Lemoine R., Vassalli J. D., Sappino A. P. LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney Int. 1994; 45: 500
   Google Scholar
• Tsukada S., Ichinose M., Miki K., Tatematsu M., Yonezawa S., Matsushima M., Kakei N., Fukamachi H., Yasugi S., Kurokawa K., et al. Tissue-and cell-specific control of guinea pig cathepsin E gene expression. Biochem. Biophys. Res. Commun. 1992; 187: 1401
   Google Scholar
• Bardsley R. G., Allcock S. M., Dawson J. M., Dumelow N. W., Higgins J. A., Lasslett Y. V., Lockley A. K., Parr T., Buttery P. J. Effect of beta-agonists on expression of calpain and calpastatin activity in skeletal muscle. Biochimie 1992; 74: 267
   Web of Science ®Google Scholar
• Chanoine J. P., Stein G. S., Braverman L. E., Shalhoub V., Lian J. B., Huber C. A., DeVito W. J. Acidic fibroblast growth factor modulates gene expression in the rat thyroid in vivo. J. Cell. Biochem. 1992; 50: 392
   Google Scholar
• van den Brule F. A., Engel J., Stetler-Stevenson W. G., Liu F. T., Sobel M. E., Castronovo V. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int. J. Cancer 1992; 52: 653
   PubMed Web of Science ®Google Scholar
• Rechberger T., Woessner J. F., Jr. Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am. J. Obstet. Gynecol. 1993; 168: 1598
   Google Scholar
• Salvesen G., Enghild J. J. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases. Biomed. Biochim. Acta 1991; 50: 665
   Google Scholar
• Neurath H., Dixon G. H. Catalysis by chymotrypsinogen. Demonstration of an acylzymogen intermediate. Biochemistry 1974; 13: 1302
   Google Scholar
• Van Wart H. E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 5578
   PubMed Web of Science ®Google Scholar
• Park A. J., Matrisian L. M., Kells A. F., Pearson R., Yuan Z., Navre M. Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the “cysteine switch”. J. Biol. Chem. 1991; 266: 1584
   Google Scholar
• Howard E. W., Bullen E. C., Banda M. J. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 1991; 266(13)064
   Google Scholar
• Chen L. C., Noelken M. E., Nagase H. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase-3 (stromelysin). Biochemistry 1993; 32(10)289
   Google Scholar
• Stack M. S., Moser T. L., Pizzo S. V. Binding of human plasminogen to basement-membrane (type IV) collagen. Biochem. J. 1992; 284: 103
   Google Scholar
• Sharma S. K., Hopkins T. R. Recent developments in the activation process of bovine chymotrypsinogen A. Bioorg. Chem. 1981; 10: 357
   Google Scholar
• Kirchheimer J. C., Binder B. R. Function of receptor-bound urokinase. Semin. Thromb. Hemost. 1991; 17: 246
   Google Scholar
• Welgus H. G. Stromelysin: structure and function. Agents Actions Suppl. 1993; 35: 61
   Google Scholar
• Crabbe T., Willenbrock F., Eaton D., Hynds P., Carne A. F., Murphy G., Docherty A. J. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry 1992; 31: 8500
   PubMed Web of Science ®Google Scholar
• Rowan A. D., Mason P., Mach L., Mort J. S. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J. Biol. Chem. 1992; 267(15)993
   Google Scholar
• Tschesche H., Knauper V., Kramer S., Michaelis J., Oberhoff R., Reinke H. Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl. 1992; 1: 245
   PubMedGoogle Scholar
• Keski-Oja J., Lohi J., Tuuttila A., Tryggvason K., Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp. Cell Res. 1992; 202: 471
   PubMed Web of Science ®Google Scholar
• Matsumoto K., Shams N. B., Hanninen L. A., Kenyon K. R. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. Curr. Eye Res. 1992; 11: 1105
   PubMed Web of Science ®Google Scholar
• Twining S. S., Kirschner S. E., Mahnke L. A., Frank D. W. Effect of Pseudomonas aeruginosa, elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest. Ophthalmol. Vis. Sci. 1993; 34: 2699
   PubMed Web of Science ®Google Scholar
• Mach L., Stuwe K., Hagen A., Ballaun C., Glossl J. Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem. J. 1992; 282: 577
   Google Scholar
• Buttle D. J., Abrahamson M., Burnett D., Mort J. S., Barrett A. J., Dando P. M., Hill S. L. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem. J. 1991; 276: 325
   PubMed Web of Science ®Google Scholar
• Michaelis J., Vissers M. C., Winter-bourn C. C. Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase. Arch. Biochem. Biophys. 1992; 292: 555
   PubMedGoogle Scholar
• Saari H., Sorsa T., Lindy O., Suomalainen K., Halinen S., Konttinen Y. T. Reactive oxygen species as regulators of human neutrophil and fibroblast interstitial col-lagenases. Int. J. Tissue React. 1992; 14: 113
   PubMedGoogle Scholar
• Shaughnessy S. G., Whaley M., Lafrenie R. M., Orr F. W. Walker-256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch. Biochem. Biophys. 1993; 304: 314
   PubMed Web of Science ®Google Scholar
• Fisher S. J., Damsky C. H. Human cytotrophoblast invasion (review). Semin. Cell Biol. 1993; 4: 183
   PubMedGoogle Scholar
• Goldberg G. I., Strongin A., Collier I. E., Genrich L. T., Marmer B. L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 1992; 267: 4583
   PubMed Web of Science ®Google Scholar
• Edelberg J. M., Weissler M., Pizzo S. V. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. Biochem. J. 1991; 276: 785
   Google Scholar
• Crabbe T., Ioannou C., Docherty A. J. P. Human progelatinase-A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur. J. Biochem. 1993; 218: 431
   PubMedGoogle Scholar
• Athauda S. B., Takahashi T., Kageyama T., Takahashi K. Autocatalytic processing of procathepsin E to cathepsin E and their structural differences. Biochem. Biophys. Res. Commun. 1991; 175: 152
   Google Scholar
• Conner G. E., Richo G. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. Biochemistry 1992; 31: 1142
   PubMed Web of Science ®Google Scholar
• Richo G., Conner G E. Proteolytic activation of human procathepsin D. Adv. Exp. Med. Biol. 1991; 306: 289
   Google Scholar
• Samarel A. M., Ferguson A. G., Decker R. S., Lesch M. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am. J. Physiol. 1989; 257: C1069
   PubMedGoogle Scholar
• Mach L., Mort J. S., GlossI J. Maturation of human procathepsin B. Proenzyne activation and proteolytic processing of the precursor of the mature proteinase. in vitro, are primarily unimolecular processes. J. Biol. Chem. 1994; 269: 13030
   PubMed Web of Science ®Google Scholar
• Murphy G., Ward R., Gavrilovic J., Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix Suppl. 1992; 1: 224
   PubMedGoogle Scholar
• Strongin A. Y., Marmer B. L., Grant G. A., Goldberg G. I. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 1993; 268(14)033
   Google Scholar
• Hoyer-Hansen G., Ronne E., Solberg H., Behrendt N., Ploug M., Lund L. R., Ellis V., Dano K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J. Biol. Chem. 1992; 267(18)224
   Google Scholar
• Geppert A. G., Binder B. R. Allosteric regulation of tPA-mediated plasminogen activation by a modifier mechanism: evidence for a binding site for plasminogen on the tPA A-chain. Arch. Biochem. Biophys. 1992; 297: 205
   Google Scholar
• Moser T. L., Enghild J. J., Pizzo S. V., Stack M. S. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. J. Biol. Chem. 1993; 268(18)917
   Google Scholar
• Stack M. S., Moser T. L., Pizzo S. V. Binding of human plasminogen to basementmembrane (type IV) collagen. Biochem. J. 1992; 284: 103
   Google Scholar
• Bendixen E., Borth W., Harpel P. C. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. J. Biol. Chem. 1993; 268(21)962
   Google Scholar
• Rijnboutt S., Stoorvogel W., Geuze H. J., Strous G. J. Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J. Biol. Chem. 1992; 267(15)665
   Google Scholar
• Wang P. H., Do Y. S., Macaulay L., Shinagawa T., Anderson P. W., Baxter J. D., Hsueh W. A. Identification of renal cathepsin B as a human prorenin-processing enzyme. J. Biol. Chem. 1991; 266(12)633
   Google Scholar
• Kuboki M., Ishii H., Horie S., Kazama M. Procalpain I in cytoplasm is translocated onto plasma and granule membranes during platelet stimulation with thrombin and then activated on the membranes. Biochem. Biophys. Res. Commun. 1992; 185: 1122
   PubMedGoogle Scholar
• Edmunds T., Nagainis P. A., Sathe S. K., Thompson V. F., Goll D. E. Comparison of the autolyzed and unautolyzed forms of mu- and m-calpain from bovine skeletal muscle. Biochim. Biophys. Acta 1991; 1077: 197
   Google Scholar
• Ishii H., Suzuki Y., Kuboki M., Mori kawa M., Inoue M., Kazama M. Activation of calpain I in thrombin-stimulated platelets is regulated by the initial elevation of the cytosolic Ca2+ concentration. Biochem. J. 1992; 284: 755
   Google Scholar
• Cottin P., Poussard S., Desmazes J. P., Georgescauld D., Ducastaing A. Free calcium and calpain I activity. Biochim. Biophys. Acta 1991; 1079: 139
   Google Scholar
• Michetti M., Viotti P. L., Melloni E., Pontremoli S. Mechanism of action of the calpain activator protein in rat skeletal muscle. Eur. J. Biochem. 1991; 202: 1177
   PubMedGoogle Scholar
• Yamamoto M., Nakagaki T., Kisiel W. Tissue factor-dependent autoactivation of human blood coagulation factor VII. J. Biol. Chem. 1992; 267(19)089
   Google Scholar
• Takahashi K., Kwaan H. C., Koh E., Tanabe M. Enzymatic properties of the phosphorylated urokinase-type plasminogen activator isolated from a human carcinomatous cell line. Biochem. Biophys. Res. Commun. 1992; 182: 1473
   Google Scholar
• Wittwer A. J., Howard S. C., Carr L. S., Harakas N. J., Feder J., Parekj R. J., Rudd P. M., Dwek R. A., Rademacher T. W. Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator. Biochemistry 1989; 28: 7662
   Google Scholar
• Masson D., Peters P. J., Geuze H. J., Borst J., Tschopp J. Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH. Biochemistry 1990; 29(11)229
   Google Scholar
• Gervasoni J. E., Conrad D. H., Hugli T. E., Schwartz L. B., Ruddy S. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan. J. Immunol. 1986; 136: 285
   Google Scholar
• Dunn W. A., Jr. Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J. Cell Biol. 1990; 110: 1935
   PubMedGoogle Scholar
• Pryer N. K., Wuestehube L. J., Schekman R. Vesicle-mediated protein sorting. Annu. Rev. Biochem. 1992; 61: 471
   PubMed Web of Science ®Google Scholar
• Wiederanders B., Bromme D., Kirschke H., von Figura K., Schmidt B., Peters C. Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S. J. Biol. Chem. 1992; 267(13)708
   Google Scholar
• Baranski T. J., Koelsch G., Hartsuck J. A., Kornfeld S. Mapping and molecular modeling of a recognition domain for lysosomal enzyme targeting. J. Biol. Chem. 1991; 266(23)365
   Google Scholar
• Rijnboutt S., Kal A. J., Geuze H. J., Aerts H., Strous G. J. Mannose 6-phosphateindependent targeting of cathepsin D to lysosomes in HepG2 cells. J. Biol. Chem. 1991; 266(23)586
   Google Scholar
• Conner G. E. The role of the cathepsin D propeptide in sorting to the lysosome. J. Biol. Chem. 1992; 267(21)738
   Google Scholar
• Prence E. M., Dong J. M., Sahagian G. G. Modulation of the transport of a lysosomal enzyme by PDGF. J. Cell Biol. 1990; 110: 319
   PubMedGoogle Scholar
• Erickson-Lawrence M., Zabludoff S. D., Wright W. W. Cyclic protein-2, a secretory product of rat Sertoli cells, is the proenzyme form of cathepsin L. Mol. Endocrin. 1991; 5: 1789
   PubMedGoogle Scholar
• Tooze J., Hollinshead M., Hensel G., Kern H. F., Hoflack B. Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur. J. Cell Biol. 1991; 56: 187
   PubMed Web of Science ®Google Scholar
• Hirano T., Saluja A., Ramarao P., Lerch M. M., Saluja M., Steer M. L. Apical secretion of lysosomal enzymes in rabbit pancreas occurs via a secretagogue regulated pathway and is increased after pancreatic duct obstruction. J. Clin. Invest. 1991; 87: 865
   PubMed Web of Science ®Google Scholar
• Baici A., Lang A. Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res. 1990; 259: 567
   Google Scholar
• Nemere I., Norman A. W. Redistribution of cathepsin B activity from the endosomal-lysosomal pathway in chick intestine within 3 min of calcium absorption. Mol. Cell. Endocrinol. 1991; 78: 7
   Google Scholar
• Dean D. D., Schwartz Z., Muniz O. E., Gomez R., Swain L. D., Howell D. S., Boyan B. D. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans. Calcif. Tissue Int. 1992; 50: 342
   PubMed Web of Science ®Google Scholar
• Travis J. Structure, function, and control of neutrophil proteinases. Am. J. Med. 1988; 84(Suppl. 6A)37
   PubMed Web of Science ®Google Scholar
• Wojtecka-Lukasik E., Maslinski S. Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation. J. Physiol. Pharmacol. 1992; 43: 173
   PubMedGoogle Scholar
• Podack E. R., Hengartner H., Lictenheld M. G. A central role of perforin in cytolysis. Annu. Rev. Immunol. 1991; 9: 129
   PubMed Web of Science ®Google Scholar
• Alter S. C., Metcalfe D. D., Bradford T. R., Schwartz L. B. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem. J. 1987; 248: 821
   PubMed Web of Science ®Google Scholar
• Travis J., Bangalore N. Biochemical mechanisms for disrupting the proteinase-proteinase inhibitor balance in tissues (review). Agents Actions 1993; 19, Suppl., 42
   Google Scholar
• Saku T., Sakai H., Shibata Y., Kato Y., Yamamoto K. An immunocytochemical study on distinct intracellular localization of cathepsin E and cathepsin D in human gastric cells and various rat cells. J. Biochem. 1991; 110: 956
   Google Scholar
• Harrison R. K., Chang B., Niedzwiecki L., Stein R. L. Mechanistic studies on the human matrix metalloproteinase stromelysin. Biochemistry 1992; 31(10)757
   Google Scholar
• Hasnain S., Hirama T., Tarn A., Mort J. S. Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses. J. Biol. Chem. 1992; 267: 4713
   Google Scholar
• Khouri H. E., Plouffe C., Hasnain S., Hirama T., Storer A. C., Menard R. A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses. Biochem. J. 1991; 275: 751
   Google Scholar
• Athauda S. B., Takahashi T., Inoue H., Ichinose M., Takahashi K. Proteolytic activity and cleavage specificity of cathepsin E at the physiological pH as examined towards the B chain of oxidized insulin. FEBS Lett. 1991; 292: 53
   PubMed Web of Science ®Google Scholar
• Koga H., Yamada H., Nishimura Y., Kato K., Imoto T. Multiple proteolytic action of rat liver cathepsin B: specificities and pH-dependencies of the endo-and exopeptidase activities. J. Biochem. 1991; 110: 179
   Google Scholar
• Young P. R., Spevacek S. M. Substratum acidification and proteinase activation by murine-B16F10 melanoma cultures. Biochim. Biophys. Acta 1993; 1182: 69
   Google Scholar
• Mann K. G., Lawson J. H. The role of the membrane in the expression of the vitamin K-dependent enzymes. Arch. Pathol. Lab. Med. 1992; 116: 1330
   PubMedGoogle Scholar
• Housley T. J., Baumann A. P., Braun I. D., Davis G., Seperack P. K., Wilhelm S. M. Recombinant Chinese hamster ovary cell matrix metalloprotease-3 (MMP-3, stromelysin-1). Role of calcium in promatrix metalloprotease-3 (pro-MMP-3, prostromelysin-1) activation and thermostability of the low mass catalytic domain of MMP-3. J. Biol. Chem. 1993; 268: 4481
   Google Scholar
• Abedodun F., Jordan F. Multinuclear magnetic resonance studies on the calcium(II) binding site in trypsin, chymotrypsin and sub-tilisin. Biochemistry 1989; 28: 7524
   Google Scholar
• Yi Z., Lindberg I. Purification and characterization of the prohormone convertase PC1(PC3). J. Biol. Chem. 1993; 268: 5615
   Google Scholar
• Mellgren R. L., Song K., Mericle M. T. m-Calpain requires DNA for activity on nuclear proteins at low calcium concentrations. J. Biol. Chem. 1993; 268: 653
   PubMedGoogle Scholar
• Pontremoli S., Melloni E., Viotti P. L., Michetti M., Salamino F., Horecker B. L. Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. Arch. Biochem. Biophys. 1991; 288: 646
   Google Scholar
• Iizuka K., Kawaguchi H., Yasuda H., Kitabatake A. The role of calcium activated neutral protease on myocardial cell injury in hypoxia. Jpn. Heart J. 1992; 33: 707
   Google Scholar
• Yoshida K., Yamasaki Y., Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion. Biochim. Biophys. Acta 1993; 1182: 215
   Google Scholar
• Thomas D. J., Richards A. D., Jupp R. A., Ueno E., Yamamoto K., Samloff I. M., Dunn B. M., Kay J. Stabilisation of cathepsin E by ATP. FEBS Lett. 1989; 243: 145
   Google Scholar
• Kageyama T., Ichinose M., Tsukada S., Miki K., Kurokawa K., Koiwai O., Tanji M., Yakabe E., Athauda S. B., Takahashi K. Gastric procathepsin E and progastricsin from guinea pig. Purification, molecular cloning of cDNAs, and characterization of enzymatic properties, with special reference to procathepsin E. J. Biol. Chem. 1992; 267(16)450
   Google Scholar
• Mach L., Mort J. S., Glossl J. Noncovalent complexes between the lysosomal proteinase cathepsin B and its propeptide account for stable, extracellular, high molecular mass forms of the enzyme. J. Biol. Chem. 1994; 269: 13036
   PubMed Web of Science ®Google Scholar
• Orlowski M. The multicatalytic proteinase complex (proteasome) and intracellular protein degradation: diverse functions of an intracellular particle (editorial; comment) (review). J. Lab. Clin. Med. 1993; 121: 187
   PubMedGoogle Scholar
• Driscoll J. The role of the proteasome in cellular protein degradation. Histology & Histopathology 1994; 9: 197
   PubMed Web of Science ®Google Scholar
• Rivett A. J., Palmer A., Knecht E. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J. Histochem. Cytochem. 1992; 40: 1165
   PubMedGoogle Scholar
• Shimbara N., Orino E., Sone S., Ogura T., Takashina M., Shono M., Tamura T., Yasuda H., Tanaka K., Ichihara A. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. J. Biol. Chem. 1992; 267(18)100
   Google Scholar
• Palmer A., Mason G. G. F., Paramio J M., Knecht E., Rivett A. J. Changes in proteasome localization during the cell cycle. Eur. J. Cell. Biol. 1994; 64: 163
   PubMed Web of Science ®Google Scholar
• Savory P. J., Rivett A. J. Leupeptin-binding site(s) in the mammalian multicatalytic proteinase complex. Biochem. J. 1993; 289: 45
   Google Scholar
• Nothwang H. G., Coux O., Bey F., Scherrer K. Prosomes and their multi-catalytic proteinase activity. Eur. J. Biochem. 1992; 207: 621
   Google Scholar
• Djaballah H., Rowe A. J., Harding S. E., Rivett A. J. The multicatalytic proteinase complex (proteasome) —structure and conformational changes associated with changes in proteolytic activity. Biochem. J. 1993; 292: 857
   Google Scholar
• Orlowski M., Cardozo C., Michaud C. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 1993; 32: 1563
   PubMed Web of Science ®Google Scholar
• Pereira M. E., Nguyen T., Wagner B. J., Margolis J. W., Yu B., Wilk S. 3,4-Dichloroisocoumarin-induced activation of the degradation of beta-casein by the bovine pituitary multicatalytic proteinase complex. J. Biol. Chem. 1992; 267: 7949
   PubMed Web of Science ®Google Scholar
• Ahn J. Y., Hong S. O., Kwak K. B., Tanaka K., Ichihara A., Ha D. B., Chung C. H. Developmental regulation of proteolytic activities and subunit pattern of 20S proteasome in chick embryonic muscle. J. Biol. Chem. 1991; 266(15)746
   Google Scholar
• Yang Y., Waters J. B., Fruh K., Peterson P. A. Proteasomes are regulated by interferon gamma: implications for antigen processing. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 4928
   Google Scholar
• Brown M. G., Driscoll J., Monaco J. J. MHC-linked low-molecular mass polypeptide subunits define distinct subsets of proteasomes. Implications for divergent function among distinct proteasome subsets. J. Immunol. 1993; 151: 1193
   Google Scholar
• Driscoll J., Brown M. G., Finley D., Monaco J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature (London) 1993; 365: 262
   PubMed Web of Science ®Google Scholar
• Tanaka K., Yoshimura T., Tamura T., Fujiwara T., Kumatori A., Ichihara A. Possible mechanism of nuclear translocation of proteasomes. FEBS Lett. 1990; 27: 41
   Google Scholar
• Weitman D., Etlinger J. D. A monoclonal antibody that distinguishes latent and active forms of the proteasome (multicatalytic proteinase complex). J. Biol. Chem. 1992; 267: 6977
   Google Scholar
• Ma C. P., Willy P. J., Slaughter C. A., Demartino G. N. PA28, an activator of the 20-S proteasome, is inactivated by proteolytic modification at its carboxyl terminus. J. Biol. Chem. 1993; 268(22)514
   Google Scholar
• Pereira M. E., Yu B., Wilk S. Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions. Arch. Biochem. Biophys. 1992; 294: 1
   Google Scholar
• Demena I. R., Mahillo E., Arribas J., Castano J. G. Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase. Biochem. J. 1993; 296: 93
   Google Scholar
• Ludemann R., Lerea K. M., Etlinger J. D. Copurification of casein kinase II with 20 S proteasomes and phosphorylation of a 30-kDa proteasome subunit. J. Biol. Chem. 1993; 268(17)413
   Google Scholar
• Tsubuki S., Saito Y., Kawashima S. Purification and characterization of an endogenous inhibitor specific to the Z-Leu-Leu-Leu-MCA Degrading activity in proteasome and its identification as heat-shock protein 90. FEBS Let. 1994; 344: 229
   PubMedGoogle Scholar
• Driscoll J., Goldberg A. L. The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J. Biol. Chem. 1990; 265: 4789
   PubMed Web of Science ®Google Scholar
• Murakami Y., Matsufuji S., Kameji T., Hayashi S.-I., Igarashi K., Tamura T., Tanaka K., Ichihara A. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitin. Nature (London) 1992; 360: 597
   PubMed Web of Science ®Google Scholar
• Ugai S., Tamura T., Tanahashi N., Takai S., Komi N., Chung C. H., Tanaka K., Ichihara A. Purification and characterization of the 26S proteasome complex catalyzing ATP-dependent breakdown of ubiquitin-ligated proteins from rat liver. J. Biochem. 1993; 113: 754
   PubMedGoogle Scholar
• Dubiel W., Pratt G., Ferrell K., Rechsteiner M. Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem. 1992; 267(22)369
   Google Scholar
• Kuehn L., Dahlmann B., Reinauer H. Evidence indicating that the multicatalytic proteinase of rabbit reticulocytes is not incorporated as a core enzyme into a 26 S proteinase complex. Arch. Biochem. Biophys. 1992; 295: 55
   Google Scholar
• Lee D. H., Kim S. S., Kim K. I., Ahn J. Y., Shim K. S., Nishigai M., Ikai A., Tamura T., Tanaka K., Ichihara A., et al. Structure and properties of the 26S protease complex from chick skeletal muscle. Biochem. Mol. Biol. Int. 1993; 30: 121
   Google Scholar
• Peters J. M., Harris J. R., Kleinschmidt J. A. infrastructure of the approximately 26S complex containing the approximately 20S cylinder particle (multicatalytic proteinase/proteasome). Eur. J. Cell Biol. 1991; 56: 422
   Google Scholar
• Armon T., Ganoth D., Hershko A. Assembly of the 26 S complex that degrades proteins ligated to ubiquitin is accompanied by the formation of ATPase activity. J. Biol. Chem. 1990; 265(20)723
   Google Scholar
• Dubiel W., Ferrell K., Pratt G., Rechsteiner M. Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family. J. Biol. Chem. 1992; 267(22)699
   Google Scholar
• Realini C., Rogers S. W., Rechsteiner M. KEKE motifs-Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors. FEBS Let. 1994; 348: 109
   Google Scholar
• Driscoll J., Frydman J., Goldberg A. L. An ATP-stabilized inhibitor of the proteasome is a component of the 1500-kDa ubiquitin conjugate-degrading complex. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 4986
   Google Scholar
• Guo G. G., Gu M. Z., Etlinger J. D. 240 kDa proteasome inhibitor (CF-2) is identical to δ-aminolevulinic acid dehydratase. J. Biol. Chem. 1994; 269: 12399
   PubMed Web of Science ®Google Scholar
• Akiyama K., Kagawa S., Tamura T., Shimbara N., Takashina M., Kristenden P., Hendil K. B., Tanaka K., Ichihara A. Replacement of proteasome subunits × and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Let. 1994; 343: 85
   PubMed Web of Science ®Google Scholar
• Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., Tanahashi N., Yoshimura T., Tanaka K., Ichihara A. Interferon-γ-induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 1994; 115: 257
   PubMed Web of Science ®Google Scholar
• Gaczynska M., Rock K. L., Goldberg A. L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes [see comments]. Nature 1993; 365: 264
   PubMed Web of Science ®Google Scholar
• Bourin M.-C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 1993; 289: 313
   PubMed Web of Science ®Google Scholar
• Walker F. J., Fay P. J. Regulation of blood coagulation by the protein C system. FASEB J. 1992; 6: 2561
   PubMed Web of Science ®Google Scholar
• Sali A., Matsumoto R., McNeil H. P., Karplus M., Stevens R. L. Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. J. Biol. Chem. 1993; 268: 9023
   PubMed Web of Science ®Google Scholar
• Stevens R. L., Kamada M. M., Serafin W. E. Structure and function of the family of proteoglycans that reside in the secretory granules of natural killer cells and other effector cells of the immune response. Curr. Top. Microbiol. Immun. 1988; 140: 93
   Google Scholar
• Church M. K., el-Lati S., Okayama Y. Biological properties of human skin mast cells. Clin. Exp. Allergy Suppl. 1991; 3: 1
   Google Scholar
• Schwartz L. B., Bradford T. R. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J. Biol. Chem. 1986; 261: 7372
   PubMed Web of Science ®Google Scholar
• Read R. J., James M. N. G. Introduction to the protein inhibitors: X-ray crystallography. Proteinase Inhibitors, A. J. Barrett, G. Salvesen. Elsevier, New York 1986; 314
   Google Scholar
• Borth W. α2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 1992; 6: 3345
   PubMed Web of Science ®Google Scholar
• Heath J K., Reynolds J. J., Meikle M. C. Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A. Biochem. Biophys. Res. Commun. 1990; 168: 1171
   Google Scholar
• Nykjaer A., Bengtssonolivecrona G., Lookene A., Moestrup S. K., Petersen C. M., Weber W., Beisiegel U., Gliemann J. The α2-macroglobulin receptor low density lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 1993; 268(15)048
   Google Scholar
• Perlmutter D. H., Glover G. I., Rivetna M., Schasteen C. S., Fallon R. J. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc. Natl. Acad. Sci. 1990; 87: 3753
   PubMed Web of Science ®Google Scholar
• Chen M., Conn K. J., Festoff B. W. A receptor for cathepsin G-α1-antitrypsin complexes on mouse spinal cord astrocytes. Neurology 1993; 43: 1223
   Google Scholar
• Abrahamson M., Mason R. W., Hansson H., Buttle D. J., Grubb A., Ohlsson K. Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem. J. 1991; 273: 621
   PubMed Web of Science ®Google Scholar
• Lenarcic B., Kos J., Dolenc I., Lucovnik P., Krizaj I., Turk V. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem. Biophys. Res. Commun. 1988; 154: 765
   PubMed Web of Science ®Google Scholar
• Koj A., Magielska-Zero D., Kurdowska A., Bereta J. Proteinase inhibitors as acute phase reactants: regulation of synthesis and turnover. Adv. Exp. Med. Biol. 1988; 240: 171
   PubMedGoogle Scholar
• Deleted in proofs
   Google Scholar
• Gettins P., Patston P. A., Schapira M. The role of conformational change in serpin structure and function (review). Bioessays 1993; 15: 461
   PubMed Web of Science ®Google Scholar
• Travis J., Garner D., Bowen J. Human α-1-antichymotrypsin: purification and properties. Biochemistry 1978; 17: 5647
   PubMed Web of Science ®Google Scholar
• Huber R., Carrell R. W. Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry 1988; 28: 8951
   Google Scholar
• Mottonen J., Strand A., Symersky J., Sweet R. M., Danley D. E., Geoghegan K. F., Gerard R. D., Goldsmith E. J. Structural basis of latency in plasminogen activator inhibitor-1. Nature (London) 1992; 355: 270
   PubMed Web of Science ®Google Scholar
• Munch M., Heegaard C. W., Andrea-sen P. A. Interconversions between active, insert and substrate forms of denatured refolded type-1 plasminogen activator inhibitor. Biochim. Biophys. Acta 1993; 1202: 29
   Google Scholar
• Matheson N. R., van Halbeek H., Travis J. Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions. J. Biol. Chem. 1991; 266(13)489
   Google Scholar
• Potempa J., Shieh B.-H., Travis J. Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. Science 1988; 241: 699
   Google Scholar
• Gaussem P., Grailhe P., Anglescano E. Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor. J. Biol. Chem. 1993; 268(12)150
   Google Scholar
• Schecter N. M., Jordan L. M., James A. M., Cooperman B. S., Wang Z. M., Rubin H. Reaction of human chymase with reactive site variants of od-anti-chymotrypsin. J. Biol. Chem. 1993; 268(23)626
   Google Scholar
• Baumann U., Huber R., Bode W., Grosse D., Lesjak M., Laurell C. B. Crystal structure of cleaved human alpha 1-anti-chymotrypsin at 2.7 Å resolution and its comparison with other serpins. J. Mol. Biol. 1991; 218: 595
   Google Scholar
• Mourey L., Samama J. P., Delarue M., Petitou M., Choay J., Moras D. Crystal structure of cleaved bovine antithrombin-III at 3.2-Angstrom resolution. J. Mol. Biol. 1993; 232: 223
   Google Scholar
• Wei A. Z., Rubin H., Cooperman B. S., Christianson D. W. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nature Structural Biology 1994; 1: 251
   PubMedGoogle Scholar
• Bjork I., Nordling K., Olson S. T. Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A β-sheet of the inhibitor during trapping of target proteinases. Biochemistry 1993; 32: 6501
   Google Scholar
• Hafeez W., Ciliberto G., Perlmutter D. H. Constitutive and modulated expression of the human alpha 1 antitrypsin gene. Different transcriptional initiation sites used in three different cell types. J. Clin. Invest. 1992; 89: 1214
   PubMed Web of Science ®Google Scholar
• Hardon E. M., Frain M., Paonessa G., Cortese R. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J. 1988; 7: 1711
   PubMed Web of Science ®Google Scholar
• Perlino E., Cortese R., Ciliberto G. The human α1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. EMBO J. 1987; 6: 2767
   PubMed Web of Science ®Google Scholar
• Castell J. V., Gomez-Lechon M. J., David M., Hirano T., Kishimoto T., Heinrich P. C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 1988; 232: 347
   PubMed Web of Science ®Google Scholar
• Perlmutter D. H., May L. T., Sehgal P. B. Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J. Clin. Invest. 1989; 84: 138
   Google Scholar
• Vassalli J. D., Huarte J., Bosco D., Sappino A. P., Sappino N., Velardi A., Wohlwend A., Erno H., Monard D., Belin D. Protease-nexin-1 as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J. 1993; 12: 1871
   Google Scholar
• Finlay T. H., Tamir S., Kadner S. S., Cruz M. R., Yavelow J., Levitz M. α(1)-Antitrypsin-independent and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology 1993; 133: 996
   PubMed Web of Science ®Google Scholar
• Kurdowska A., Travis J. Acute phase protein stimulation by alpha 1-antichymotrypsin-cathepsin G complexes. Evidence for the involvement of interleukin-6. J. Biol. Chem. 1990; 265(21)023
   Google Scholar
• Barbey-Morel C., Perlmutter D. H. Effect of Pseudomonas elastase on human mononuclear phagocyte α1-antitrypsin expression. Pediatr. Res. 1991; 29: 133
   Google Scholar
• Schwartz B. S., Bradshaw J. D. Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein. J. Biol. Chem. 1992; 267: 7089
   PubMedGoogle Scholar
• Zoellner H., Wojta J., Gallicchio M L, McGrath K., Hamilton J. A. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis. Thromb. Haemost. 1993; 69: 135
   PubMed Web of Science ®Google Scholar
• Bergman D., Kadner S. S., Cruz M. R., Esterman A. L., Tahery M. M., Young B. K., Finlay T. H. Synthesis of α1-antichymotrypsin and α-1-antitrypsin by human trophoblast. Pediatr. Res. 1993; 34: 312
   Google Scholar
• Mackiewicz A., Laciak M., Gorny A., Baumann H. Leukemia inhibitory factor, interferon-γ and dexamethasone regulate N-glycosylation of α-1-protease inhibitor in human hepatoma cells. Eur. J. Cell Biol. 1993; 60: 331
   Google Scholar
• Jensen P. H., Lorand L., Ebbesen P., Gliemann J. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIII(a)-transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. Biochem. 1993; 214: 141
   Google Scholar
• Vercaigne-Marko D., Davril M., Laine A., Hayem A. Interaction of human α1-proteinase inhibitor with human leukocyte cathepsin G. Biol. Chem. Hoppe-Seyler 1985; 366: 655
   PubMed Web of Science ®Google Scholar
• Hook V. Y. H., Purviance R. T., Azaryan A. V., Hubbard G., Krieger T. J. Purification and characterization of α1-antichymotrypsin-like protease inhibitor that regulates prohormone thiol protease involved in enkephalin precursor processing. J. Biol. Chem. 1993; 268(20)570
   Google Scholar
• Evans D. L., McGrogan M., Scott R. W., Carrell R. W. Protease specificity and heparin binding and activation of recombinant protease nexin I. J. Biol. Chem. 1991; 266(22)307
   Google Scholar
• Bourin M. C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 1993; 289: 313
   PubMed Web of Science ®Google Scholar
• Gebbink R. K., Reynolds C. H., Tollefsen D. M., Mertens K., Pannekoek H. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1. Biochemistry 1993; 32: 1675
   Google Scholar
• Faller B., Cadene M., Bieth J. G. Demonstration of a 2-step reaction mechanism for the inhibition of heparin-bound neutrophil elastase by α1-proteinase inhibitor. Biochemistry 1993; 32: 9230
   Google Scholar
• Salier J. P. Inter-alpha-trypsin inhibitor: emergence of a family within the Kunitz-type protease inhibitor superfamily (review). Trends Biochem. Sci. 1990; 15: 435
   PubMed Web of Science ®Google Scholar
• Yoshida E., Sumi H., Tsushima H., Maruyama M., Mihara H. Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohis-tochemical study. Inflammation 1991; 15: 71
   Google Scholar
• Ikeo K., Takahashi K., Gojobori T. Evolutionary origin of a Kunitz-type trypsin inhibitor domain inserted in the amyloid beta precursor protein of Alzheimer's disease. J. Mol. Evol. 1992; 34: 536
   Google Scholar
• Gebhard W., Hochstrasser K., Fritz H., Enghild J. J., Pizzo S. V., Salvesen G. Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology (review). Biol. Chem. Hoppe-Seyler 1990; 371(Suppl.)13
   PubMed Web of Science ®Google Scholar
• Diarra-Mehrpour M., Bourguignon J., Sesboue R., Mattei M. G., Passage E., Saiier J. P., Martin J. P. Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. Eur. J. Biochem. 1989; 179: 147
   PubMedGoogle Scholar
• Vetr H., Gebhard W. Structure of the human alpha 1-microglobulin-bikunin gene. Biol. Chem. Hoppe-Seyler 1990; 371: 1185
   Google Scholar
• Lindqvist A., Bratt T., Altieri M., Kastern W., Akerstrom B. Rat alpha 1-microglobulin: co-expression in liver with the light chain of inter-alpha-trypsin inhibitor. Biochim. Biophys. Acta 1992; 1130: 63
   PubMedGoogle Scholar
• Bratt T., Olsson H., Sjoberg E. M., Jergil B., Akerstrom B. Cleavage of the alpha 1-microglobulin-bikunin precursor is localized to the Golgi apparatus of rat liver cells. Biochim. Biophys. Acta 1993; 1157: 147
   PubMedGoogle Scholar
• Enghild J. J., Salvesen G., Thogersen I. B., Valnickova Z., Pizzo S. V., Hefta S. A. Presence of the protein-glycosaminogly-can protein covalent cross-link in the inter-α-inhibitor-related proteinase inhibitor heavy chain-2, bikunin. J. Biol. Chem. 1993; 268: 8711
   PubMed Web of Science ®Google Scholar
• Selloum L., Davril M., Mizon C., Balduyck M., Mizon J. The effect of the glycosaminoglycan chain removal on some properties of the human urinary trypsin inhibitor. Biol. Chem. Hoppe-Seyler 1987; 368: 47
   Google Scholar
• Potempa J., Kwon K., Chawla R., Travis J. Inter-alpha-trypsin inhibitor. Inhibition spectrum of native and derived forms. J. Biol. Chem. 1989; 264(15)109
   Google Scholar
• Pratt C. W., Pizzo S. V. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor. Arch. Biochem. Biophys. 1986; 248: 587
   Google Scholar
• Pratt C. W., Roche P. A., Pizzo S. V. The role of inter-alpha-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin. Arch. Biochem. Biophys. 1987; 258: 591
   Google Scholar
• Quon D., Wang Y., Catalano R., Scardina J. M., Murakami K., Cordell B. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature (London) 1991; 352: 239
   PubMed Web of Science ®Google Scholar
• Kido H., Fukutomi A., Schilling J., Wang Y., Cordell B., Katunuma N. Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursor. Biochem. Biophys. Res. Commun. 1990; 167: 716
   Google Scholar
• Andrews J. L., Melrose J., Ghosh P. A comparative study of the low-molecular mass serine proteinase inhibitors of human connective tissues. Biol. Chem. Hoppe-Seyler 1992; 373: 111
   Google Scholar
• Boudier C., Bieth J. G. The proteinase: mucus proteinase inhibitor binding stoichiometry. J. Biol. Chem. 1992; 267: 4370
   Google Scholar
• Abbinantenissen J. M., Simpson L. G., Leikauf G. D. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 1993; 265: L286
   Google Scholar
• Ying Q.-K., Simon S. R. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. Biochemistry 1993; 32: 1866
   PubMed Web of Science ®Google Scholar
• Sallenave J. M., Silva A. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell Mol. Biol. 1993; 8: 439
   Google Scholar
• Sallenave J. M., Marsden M. D., Ryle A. P. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe-Seyler 1992; 373: 27
   Google Scholar
• Molhuizen H. O. F., Alkemade H. A. C., Zeeuwen P. L. J. M., Dejongh G. J., Wieringa B., Schalkwijk J. SKALP/elafin — an elastase inhibitor from cultured human keratinocytes — purification, cDNA sequence, and evidence for transglutaminase cross-linking. J. Biol. Chem. 1993; 268(12)028
   Google Scholar
• Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991; 285: 213
   PubMed Web of Science ®Google Scholar
• Freije J. P., Balbin M., Abrahamson M., Velasco G., Dalboge H., Grubb A., Lopez-Otin C. Human cystatin D. cDNA cloning, characterization of the Escherichia coli, expressed inhibitor, and identification of the native protein in saliva. J. Biol. Chem. 1993; 268(15)737
   Google Scholar
• Baricos W. H., Cortez S. L., Le Q. C., Zhou Y. W., Dicarlo R. M., O'Connor S. E., Shah S. V. Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli. Kidney Int. 1990; 38: 395
   Google Scholar
• Korant B., Towatari T., Kelley M., Brzin J., Lenarcic B., Turk V. Interactions between a viral protease and cystatins. Biol. Chem. Hoppe-Seyler 1988; 369: 281
   Google Scholar
• Bradford H. N., Jameson B. A., Adam A. A., Wassell R. P., Colman R. W. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain. J. Biol. Chem. 1993; 268(26)546
   Google Scholar
• Kawasaki H., Emori Y., Suzuki K. Calpastatin has two distinct sites for interaction with calpain — effect of calpastatin fragments on the binding of calpain to membranes. Arch. Biochem. Biophys. 1993; 305: 467
   PubMedGoogle Scholar
• Nishimura T., Goll D. E. Binding of calpain fragments to calpastatin. J. Biol. Chem. 1991; 266(11)842
   Google Scholar
• Adachi Y., Ishida-Takahashi A., Taka-hashi C., Takano E., Murachi T., Hatanaka M. Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells. J. Biol. Chem. 1991; 266: 3968
   Google Scholar
• Pontremoli S., Viotti P. L., Michetti M., Salamino F., Sparatore B., Melloni E. Modulation of inhibitory efficiency of rat skeletal muscle calpastatin by phosphorylation. Biochem. Biophys. Res. Commun. 1992; 187: 751
   Google Scholar
• Murphy G. The regulation of connective tissue metalloproteinases by natural inhibitors. Agents Actions Suppl. 1993; 35: 69
   Google Scholar
• Baragi V. M., Fliszar C. J., Conroy M. C., Ye Q.-Z., Shipley J. M., Welgus H. G. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. J. Biol. Chem. 1994; 269(12)692
   Google Scholar
• Kleiner D. E., Jr., Tuuttila A., Tryggvason K., Stetler-Stevenson W. G. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 1993; 32: 1583
   PubMed Web of Science ®Google Scholar
• Willenbrock F., Crabbe T., Slocombe P. M., Sutton C. W., Docherty A. J., Cockett M. I., O'Shea M., Brocklehurst K., Phillips I. R., Murphy G. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 1993; 32: 4330
   PubMed Web of Science ®Google Scholar
• Banda M. J., Howard E. W., Herron G. S., Apodaca G. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP. Matrix Suppl. 1992; 1: 294
   Google Scholar
• Heath J. K., Reynolds J. J., Meikle M. C. Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A. Biochem. Biophys. Res. Commun. 1990; 168: 1171
   Google Scholar
• Sato T., Ito A., Mori Y. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem. Biophys. Res. Commun. 1990; 170: 824
   PubMed Web of Science ®Google Scholar
• Shapiro S. D., Kobayashi D. K., Welgus H. G. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J. Biol. Chem. 1992; 267(13)890
   Google Scholar
• Stetler-Stevenson W. G., Brown P. D., Onisto M., Levy A. T., Liotta L. A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 1990; 265(13)933
   Google Scholar
• Jacobsen L., Sottrup-Jensen L. Localization of lysyl- -glutamyl cross-links in α2-macroglobulin-plasmin complex. Biochemistry 1993; 32: 120
   Google Scholar
• Fusek M., Mares M., Vagner J., Voburka Z., Baudys M. Inhibition of aspartic proteinases by propart peptides of human procathepsin D and chicken pepsinogen. FEBS Lett. 1991; 5: 160
   Google Scholar
• Harboe M., Andersen P. M., Foltmann B., Kay J., Kassell B. The activation of bovine pepsinogen. Sequence of the peptides released, identification of a pepsin inhibitor. J. Biol. Chem. 1974; 249: 4487
   Google Scholar
• Thomas D. J., Richards A. D., Kay J. Inhibition of aspartic proteinases by alpha 2-macroglobulin. Biochem. J. 1989; 259: 905
   Google Scholar
• Marshall C. J. Evolutionary relationships among the serpins. Philos. Trans. R. Soc. London Ser. B 1993; 342: 101
   PubMedGoogle Scholar
• Detain E., Pochon F., Barray M., Van Leuven F. Ultrastructure of alpha 2-macroglobulins. Electron Microsc. Rev. 1992; 5: 231
   Google Scholar
• Sottrup-Jensen L., Birkedal-Hansen H. Localization of cleavage sites for human fibroblast collagenase in the bait region of five mammalian alpha-macroglobulins. Matrix Suppl. 1992; 1: 263
   PubMedGoogle Scholar
• Marshall L. B., Figler N. L., Gonias S. L. Identification of α2-macroglobulin conformational intermediates by electron microscopy and image analysis. Comparison of α2-macroglobulin-thrombin and α2-macroglobulin reacted with cis-dichlorodiammineplatinum(II) and trypsin. J. Biol. Chem. 1992; 267: 6347
   Google Scholar
• Mason R. W. Interaction of lysosomal cysteine proteinases with alpha 2-macroglobulin: conclusive evidence for the endopepti-dase activities of cathepsins B and H. Arch. Biochem. Biophys. 1989; 273: 367
   PubMedGoogle Scholar
• LaMarre J., WoJlenberg G. K., Gonias S. L., Hayes M. A. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab. Invest. 1991; 65: 3
   PubMed Web of Science ®Google Scholar
• Rubenstein D. S., Thogersen I. B., Pizzo S. V., Enghild J. J. Identification of monomelic α-macroglobulin proteinase inhibitors in birds, reptiles, amphibians and mammals, and purification and characterization of a monomelic α-macroglobulin proteinase inhibitor from the American bullfrog Rana catesbiana. Biochem. J. 1993; 290: 85
   Google Scholar
• Gaddy-Kurten D., Richards J. S. Regulation of α2-macroglobulin by luteinizing hormone and prolactin during cell differentiation in the rat ovary. Mol. Endocrinol. 1991; 5: 1280
   Google Scholar
• Twining S. S., Fukuchi T., Yue B. Y. J. T., Wilson P. M., Zhou X., Loushin G. α2-Macroglobulin is present in and synthesized by the cornea. Invest. Ophthalmol. Vis. Sci., in press
   Google Scholar
• Matthijs G., Devriendt K., Cassiman J. J., Van den Berghe H., Marynen P. Structure of the human alpha-2 macroglobulin gene and its promoter. Biochem. Biophys. Res. Commun. 1992; 184: 596
   Google Scholar
• Krause E., Wegenka U., Moller C., Horn F., Heinrich P. C. Gene expression of the high molecular weight proteinase inhibitor α2-macroglobulin. Biol. Chem. Hoppe-Seyler 1992; 373: 509
   PubMedGoogle Scholar
• Ganter U., Strauss S., Jonas U., Weide-mann A., Beyreuther K., Volk B., Berger M., Bauer J. α2-Macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer β-amyloid precursor protein. FEBS Lett. 1991; 282: 127
   PubMedGoogle Scholar
• Kittas C., Aroni K., Matani A., Papadimitriou C. S. Immunocytochemical demonstration of a1-antitrypsin and a1-antichymotrypsin in human gastrointestinal tract. Hepato-Gastroenterology 1982; 29: 275
   Google Scholar
• Steffens G. J., Heinzel-Wieland R., Saunders D., Wolf B., Rudolphus A., Stolk J., Kramps J. A., Dijkman J. A. Oxidation resistant muteins of antileukoproteinase as potential therapeutic agents. Agents Actions Suppl. 1993; 42: 111
   Google Scholar
• Strandberg L., Lawrence D. A., Johanson L. B.-A., Ny T. The oxidative inactivation of plasminogen activator inhibitor type 1 results from a conformational change in the molecule and does not require the involvement of the P1 methionine. J. Biol. Chem. 1991; 266(13)852
   Google Scholar
• Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 1980; 255: 3931
   PubMed Web of Science ®Google Scholar
• Winyard P. G., Zhang Z., Chidwick K., Blake D. R., Carrell R. W., Murphy G. Proteolytic inactivation of human α1-antitrypsin by human stromelysin. FEBS Lett. 1991; 279: 91
   Google Scholar
• Desrochers P. E., Mookhtiar K., Van Wart H. E., Hasty K. A., Weiss S. J. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 1992; 267: 5005
   Google Scholar
• Mast A. E., Enghild J. J., Nagase H., Suzuki K., Pizzo S. V., Salvesen G. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin). J. Biol. Chem. 1991; 266(15)810
   Google Scholar
• Lenarcic B., Krasovec M., Ritonja A., Olafsson I., Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991; 280: 211
   PubMed Web of Science ®Google Scholar
• Sponer M., Nick H. P., Schnebli H. P. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol. Chem. Hoppe-Seyler 1991; 372: 963
   PubMed Web of Science ®Google Scholar
• Morihara K., Sanai Y., Tsuzuki H., Jyoyama H., Hirose K., Homma J. Y., Kato I. Effects of proteases on the structure and activity of Pseudomonas aeruginosa, exotoxin A. Infect. Immun. 1981; 34: 435
   Google Scholar
• Maeda H., Molla A. Pathogenic potentials of bacterial proteases. Clin. Chim. Acta 1989; 185: 357
   PubMed Web of Science ®Google Scholar
• Blank C. A., Brantly M. Clinical features and molecular characteristics of allin: conclusive evidence for the endopeptidase activities of cathepsins B and H. Arch. Biochem. Biophys. 1989; 273: 367
   Google Scholar
• LaMarre J., WoJlenberg G. K., Gonias S. L., Hayes M. A. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab. Invest. 1991; 65: 3
   PubMed Web of Science ®Google Scholar
• Rubenstein D. S., Thogersen I. B., Pizzo S. V., Enghild J. J. Identification of monomelic α-macroglobulin proteinase inhibitors in birds, reptiles, amphibians and mammals, and purification and characterization of a monomelic α-macroglobulin proteinase inhibitor from the American bullfrog Rana catesbiana. Biochem. J. 1993; 290: 85
   Google Scholar
• Gaddy-Kurten D., Richards J. S. Regulation of α2-macroglobulin by luteinizing hormone and prolactin during cell differentiation in the rat ovary. Mol. Endocrinol. 1991; 5: 1280
   Google Scholar
• Twining S. S., Fukuchi T., Yue B. Y. J. T., Wilson P. M., Zhou X., Loushin G. α2-Macrog]obulin is present in and synthesized by the cornea. Invest. Ophthalmol. Vis. Sci., in press
   Google Scholar
• Matthijs G., Devriendt K., Cassiman J. J., Van den Berghe H., Marynen P. Structure of the human alpha-2 macroglobulin gene and its promoter. Biochem. Biophys. Res. Commun. 1992; 184: 596
   Google Scholar
• Krause E., Wegenka U., Moller C., Horn F., Heinrich P. C. Gene expression of the high molecular weight proteinase inhibitor α2-macroglobulin. Biol. Chem. Hoppe-Seyler 1992; 373: 509
   PubMedGoogle Scholar
• Ganter U., Strauss S., Jonas U., Weidemann A., Beyreuther K., Volk B., Berger M., Bauer J. α2-Macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer β-amyloid precursor protein. FEBS Lett. 1991; 282: 127
   PubMedGoogle Scholar
• Kittas C., Aroni K., Matani A., Papadimitriou C. S. Immunocytochemical demonstration of a1-antitrypsin and a1-anti-chymotrypsin in human gastrointestinal tract. Hepato-Gastroenterology 1982; 29: 275
   Google Scholar
• Steffens G. J., Heinzel-Wieland R., Saunders D., Wolf B., Rudolphus A., Stolk J., Kramps J. A., Dijkman J. A. Oxidation resistant muteins of antileukoproteinase as potential therapeutic agents. Agents Actions Suppl. 1993; 42: 111
   Google Scholar
• Strandberg L., Lawrence D. A., Johanson L. B.-A., Ny T. The oxidative inactivation of plasminogen activator inhibitor type 1 results from a conformational change in the molecule and does not require the involvement of the P1 methionine. J. Biol. Chem. 1991; 266(13)852
   Google Scholar
• Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 1980; 255: 3931
   PubMed Web of Science ®Google Scholar
• Winyard P. G., Zhang Z., Chidwick K., Blake D. R., Carrell R. W., Murphy G. Proteolytic inactivation of human α1-antitrypsin by human stromelysin. FEBS Lett. 1991; 279: 91
   Google Scholar
• Desrochers P. E., Mookhtiar K., Van Wart H. E., Hasty K. A., Weiss S. J. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 1992; 267: 5005
   Google Scholar
• Mast A. E., Enghild J. J., Nagase H., Suzuki K., Pizzo S. V., Salvesen G. Kinetics and physiologic relevance of the inactivation of alpha 1 -proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin). J. Biol. Chem. 1991; 266(15)810
   Google Scholar
• Lenarcic B., Krasovec M., Ritonja A., Olafsson I., Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991; 280: 211
   PubMed Web of Science ®Google Scholar
• Sponer M., Nick H. P., Schnebli H. P. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol. Chem. Hoppe-Seyler 1991; 372: 963
   PubMed Web of Science ®Google Scholar
• Morihara K., Sanai Y., Tsuzuki H., Jyoyama H., Hirose K., Homma J. Y., Kato I. Effects of proteases on the structure and activity of Pseudomonas aeruginosa, exotoxin A. Infect. Immun. 1981; 34: 435
   Google Scholar
• Maeda H., Molla A. Pathogenic potentials of bacterial proteases. Clin. Chim. Acta 1989; 185: 357
   PubMed Web of Science ®Google Scholar
• Blank C. A., Brantly M. Clinical features and molecular characteristics of α1-antitrypsin deficiency. Ann. Allerg. 1994; 72: 105
   PubMedGoogle Scholar
• Poller W., Faber J. P., Weidinger S., Tief K., Scholz S., Fischer M., Olek K., Kirchgesser M., Heidtmann H. H. A leucine-to-proline substitution causes a defective α1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993; 17: 740
   PubMed Web of Science ®Google Scholar
• Birrer P. Consequences of unbalanced protease in the lung: protease involvement in destruction and local defense mechanisms of the lung. Agents Act. — Suppl. 1993; 40: 3
   Google Scholar
• Kalaria R. N., Golde T., Kroon S. N., Perry G. Serine protease inhibitor anti-thrombin-III and its messenger RNA in the pathogenesis of Alzheimers disease. Am. J. Pathol. 1993; 143: 886
   Google Scholar
• Ishiguro K., Shoji M., Yamaguchi H., Matsubara E., Ikeda M., Kawarabayashi T., Harigaya Y., Okamoto K., Hirai S. Differential expression of α1-antichymotrypsin in the aged human brain. Virchows Arch. B 1993; 64: 221
   Google Scholar
• Larvin M., Mayer A. D., McMahon M. M., Muller-Esterl W., Fritz H. Intra-peritoneal aprotinin therapy for acute pancreatitis. Biol. Chem. Hoppe-Seyler 1988; 369: 145
   Google Scholar
• Tervo T., van Setten G. B., Tervo K., Tarkkanen A. Experience with plasmin inhibitors. Acta Ophthalmol., Suppl. 1992; 47
   Google Scholar
• Bailey C. R., Kelleher A. A., Wielogorski A. K. Randomized placebocontrolled double-blind study of three aprotinin regimens in primary cardiac surgery. British Journal of Surgery 1994; 81: 969
   Google Scholar
• Mulligan M. S., Desrochers P. E., Chinnaiyan A. M., Gibbs D. F., Varani J., Johnson K. J., Weiss S. J. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metallo-proteinases-2. Proc. Natl. Acad. Sci. 1993; 90: 11523
   PubMedGoogle Scholar
• Schultz R. M., Silberman S., Persky B., Bajkowski A. S., Carmichael D. F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F-10 melanoma cells. Cancer Res. 1988; 48: 5539
   PubMed Web of Science ®Google Scholar
• Stack M. S., Pizzo M. S. Effect of desialylation on the biological properties of human plasminogen. Biochem. J. 1992; 284: 81
   PubMedGoogle Scholar
• Knauper V., Osthues A., DeClerck Y. A., Langley K. E., Blaser J., Tschesche H. Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem. J. 1993; 291: 847
   Google Scholar
• Sorimachi H., Toyama-Sorimachi N., Saido T. C., Kawasaki H., Sugita H., Miyasaka M., Arahata K., Ishiura S., Suzuki K. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem. 1993; 268(10)593
   Google Scholar
• Demunk G. A. W., Parkinson J. F., Groeneveld E., Bang N. U., Rijken D. C. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin. Biochem. J. 1993; 290: 655
   Google Scholar
• Williams S. E., Ashcom J. D., Argraves W. S., Strickland D. K. A novel mechanism for controlling the activity of α2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J. Biol. Chem. 1992; 267: 9035
   PubMedGoogle Scholar
• Wolf B. B., Lopes M. B., VandenBerg S. R., Gonias S. L. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 1992; 141: 37
   Google Scholar
• Van Leuven F., Marynen P., Cassiman J. J., Van den Berghe H. Mapping of structure-function relationships in proteins with a panel of monoclonal antibodies. A study on human alpha 2-macroglobulin. J. Immunol. Methods 1988; 111: 39
   Google Scholar
• Figler N. L., Strickland D. K., Allietta M., Gonias S. L. Immunoelectron microscopy studies with a monoclonal antibody directed against a receptor recognition site epitope in human alpha 2-macroglobulin. J. Struct. Biol. 1991; 106: 237
   Google Scholar
• Moestrup S. K., Gliemann J. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macro-globulin-proteinase complex is achieved by binding to adjacent receptors. J. Biol. Chem. 1991; 266(14)011
   Google Scholar
• Gafvels M. E., Coukos G., Sayegh R., Coutifaris C., Strickland D. K., Strauss J. F. Regulated expression of the trophoblast α-2-macroglobulin receptor/low density lipoprotein receptor-related protein. J. Biol. Chem. 1994; 267(21)230
   Google Scholar
• Nykjaer A., Petersen C. M., Moller B., Jensen P. H., Moestrup S. K., Holtet T. L., Etzerodt M., Thogersen H. C., Munch M., Andreasen P. A., et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase. plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 1992; 267: 14543
   PubMed Web of Science ®Google Scholar
• LaMarre J., Wolf B. B., Kittler E. L. W., Quesenberry P. J., Gonias S. L. Regulation of macrophage α2-macroglobulin receptor low density lipoprotein receptor related protein by lipopolysaccharide and interferon-gamma. J. Clin. Invest. 1993; 91: 1219
   Google Scholar
• Meyer K. C., Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J. Lab. Clin. Med. 1993; 121: 654
   PubMedGoogle Scholar
• Twining S. S., Davis S. D., Hyndiuk R. A. Relationship between proteases and descemetocele formation in experimental Pseudomonas, keratitis. Curr. Eye Res. 1986; 5: 503
   PubMed Web of Science ®Google Scholar
• Steuhl K. P., Doring G., Thiel H. J. The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa. Fortschr. Ophthalmol. 1989; 86: 283
   PubMedGoogle Scholar
• Levine J. J., Sherry D. D., Strickland D. K., Ilowite N. T. Intraarticular α2-macroglobulin complexes and proteolytic activity in children with juvenile rheumatoid arthritis. Pediatr. Res. 1993; 34: 204
   Google Scholar
• Pakdel F., Le Goff P., Katzen-ellenbogen B. S. An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity. J. Steroid Biochem. Mol. Biol. 1993; 46: 663
   PubMedGoogle Scholar
• Terlecky S. R., Dice J. F. Polypeptide import and degradation by isolated lysosomes. J. Biol. Chem. 1993; 268(23)490
   Google Scholar
• Stadtman E. R. Protein oxidation and aging. Science 1992; 257: 1220
   PubMed Web of Science ®Google Scholar
• Opdenakker G., Rudd P. M., Ponting C. P., Dwek R. A. Concepts and principles of glycobiology. FASEB J. 1993; 7: 1330
   PubMedGoogle Scholar
• Johnson G. V., Greenwood J. A., Costello A. C., Troncoso J. C. The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain. Neurochem. Res. 1991; 16: 869
   PubMed Web of Science ®Google Scholar
• Netzel-Arnett S., Sang Q. X., Moore W. G., Navre M., Birkedal-Hansen H., Van Wart H. E. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 1993; 32: 6427
   PubMed Web of Science ®Google Scholar
• Leduc R., Molloy S. S., Thorne B. A., Thomas G. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J. Biol. Chem. 1992; 267(14)304
   Google Scholar
• Smith L. K., Bradshaw M., Croall D. E., Garner C. W. The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Biochem. Biophys. Res. Commun. 1993; 196: 767
   PubMedGoogle Scholar
• Hershko A., Ciechanover A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 1992; 61: 761
   PubMed Web of Science ®Google Scholar
• Dice J. F. Selective degradation of cytosolic proteins by lysosomes (review). Ann. N.Y. Acad. Sci. 1992; 674: 58
   Google Scholar
• Elvira M., Diez J. A., Wang K. K., Villalobo A. Phosphorylation of connexin-32 by protein kinase C prevents its proteolysis by mu-calpain and m-calpain. J. Biol. Chem. 1993; 268(14)294
   Google Scholar
• Zolotarjova N., Ho C., Mellgren R. L., Askari A., Huang W. H. Different sensitivities of native and oxidized forms of Na+/K+-ATPase to intracellular proteinases. Biochimica et Biophysica Acta — Biomem-branes 1994; 1192: 125
   Google Scholar
• Pacifici R. E., Kono Y., Davies K. J. A. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex proteasome. J. Biol. Chem. 1993; 268(15)405
   Google Scholar
• Giulivi C., Davies K. J. A. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19-S) proteasome. J. Biol. Chem. 1993; 268: 8752
   PubMed Web of Science ®Google Scholar
• Chau V., Bachmair A., Marriott D., Ecker D. J., Gonda D. K., Varshavsky A. A multiubiquitin chain is confined to a specific lysine in a targeted short-lived protein. Science 1989; 243: 1576
   PubMed Web of Science ®Google Scholar
• Vannocker S., Vierstra R. D. Multiubiquitin chains linked through lysine-48 are abundant in vivo and are competent intermediates in the ubiquitin proteolytic pathway. J. Biol. Chem. 1993; 268: 24766
   Google Scholar
• Morris R., Winyard P. G., Blake D. R., Morris C. J. Thrombin in inflammation and healing, Relevance to rheumatoid arthritis. Ann. Rheum. Dis. 1994; 53: 72
   Google Scholar
• Kikuchi H., Tanaka S., Matsuo O. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. J. Rheumatol. 1987; 14: 439
   Google Scholar
• Duffy M. J. Urokinanase-type plasminogen activator and malignancy. Fibrinolysis 1993; 7: 295
   Google Scholar
• Sloane B. F., Moin K., Krepela E., Rozhim J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Can. Metast. Rev. 1990; 9: 333
   PubMed Web of Science ®Google Scholar
• Blasi F. Molecular mechanisms of protease-mediated tumor invasiveness. J. Surg. Oncol. 1993; S321
   Google Scholar
• Reinartz J., Naher H., Mai H., Kramer M. D. Plasmogen activation in lesional skin of pemphigus-vulgaris type neumann. Arch. Dermatol. Res. 1993; 284: 432
   Google Scholar
• Kramer M. D., Reinartz J. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/α2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin. J. Clin. Invest. 1993; 92: 978
   PubMed Web of Science ®Google Scholar
• Tooyama I., Kawamata T., Akiyama H., Moestrup S. K., Gliemann J., McGeer P. L. Immunohistochemical study of α2-macroglobulin receptor in Alzheimer and control postmortem human brain. Mol. Chem. Neuropathol. 1993; 18: 153
   PubMedGoogle Scholar
• Miyazaki K., Hasegawa M., Funahashi K., Umeda M. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature (London) 1993; 362: 839
   PubMedGoogle Scholar
• Hamilton J. A., Hart P. H., Leizer T., Vitti G. F., Campbell I. K. Regulation of plasminogen activator activity in arthritic joints. J. Rheumatol. 1991; 18(Suppl.)106
   Google Scholar
• Niedbala M. J., Stein-Picarella M. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 1993; 81: 2608
   Google Scholar
• Immonen I., Siren V., Stephens R. W., Liesto K., Vaheri A. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture. Invest. Ophthalmol. Vis. Sci. 1993; 34: 2062
   PubMedGoogle Scholar
• Wojta J., Gallicchio M., Zoellner H., Filonzi E. L., Hamilton J. A., McGrath K. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 1993; 81: 3285
   PubMedGoogle Scholar
• Gerwin B. I., Keski-Oja J., Seddon M., Lechner J. F., Harris C. C. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am. J. Physiol. 1990; 259: L262
   Google Scholar
• Thompson J. N., Nelles L., Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur. J. Biochem. 1991; 201: 627
   Google Scholar
• Baici A., Lang A. Effect of interleukin-1 beta on the production of cathepsin B by rabbit articular chondrocytes. FEBSLett. 1990; 277: 93
   Google Scholar
• Nilsen-Hamilton M., Jang Y. J., Delgado M., Shim J. K., Bruns K., Chiang C. P., Fang Y., Parfett C. L., Denhardt D. T., Hamilton R. T. Regulation of the expression of mitogen-regulated protein (MRP; proliferin) and cathepsin L in cultured cells and in the murine placenta. Mol. Cell. Endocrinol 1991; 77: 115
   PubMedGoogle Scholar
• Troen B. R., Chauhan S. S., Ray D., Gottesman M. M. Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters. Cell Growth Differ. 1991; 2: 23
   PubMedGoogle Scholar
• Scott D. K., Brakenhoff K. D., Clohisy J. C., Quinn C. O., Partridge N. C. Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3′,5′-monophosphate and requiring protein synthesis. Mol. Endocrinol 1992; 6: 2153
   PubMedGoogle Scholar
• Gronowicz G., Hadjimichael J., Richards D., Cerami A., Rossomando E. F. Correlation between tumor necrosis factor-alpha (TNF-alpha)-induced cytoskeletal changes and human collagenase gene induction. J. Periodont. Res. 1992; 27: 562
   Google Scholar
• Hiraoka K., Sasaguri Y., Komiya S., Inoue A., Morimatsu M. Cell proliferation-related production of matrix metallo-proteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts. Biochem. Int. 1992; 27: 1083
   Google Scholar
• Saarialho-Kere U. K., Welgus H. G., Parks W. C. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 1993; 268(17)354
   Google Scholar
• Bazan H. E., Tao Y., Bazan N. G. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 8678
   PubMed Web of Science ®Google Scholar
• Kolkenbrock H., Heckerkia A., Orgel D., Buchlow G., Sorensen H., Hauer W., Ulbrich N. A trypsin sensitive stromelysin isolated from rheumatoid synovial fluid is an activator for matrix metalloproteinases. Eur. J. Clin. Chem. Clin. Biochem. 1993; 31: 625
   Google Scholar
• Montgomery A. M., Sabzevari H., Reisfetd R. A. Production and regulation of gelatinase B by human T-cells. Biochim. Biophys. Acta 1993; 1176: 265
   PubMed Web of Science ®Google Scholar
• Wahl S. M., Allen J. B., Weeks B. S., Wong H. L., Klotman P. E. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 4577
   PubMed Web of Science ®Google Scholar
• Lacraz S., Nicod L., Galve-de Roche-monteix B., Baumberger C., Dayer J. M., Welgus H. G. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 1992; 90: 382
   PubMed Web of Science ®Google Scholar
• Windsor L. J., Grenett H., Birkedal-Hansen B., Bodden M. K., Engler J. A., Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines andphorbolesters. J. Biol. Chem. 1993; 268(17)341
   Google Scholar
• Fletcher S., Thomas T., Schreiber G., Heinrich P. C., Yeoh G. C. The development of rat alpha 2-macroglobulin. Studies in vivo and in cultured fetal rat hepatocytes. Eur. J. Biochem. 1988; 171: 703
   Google Scholar
• Gebicke-Haerter P. J., Bauer J., Brenner A., Gerok W. Alpha 2-macroglobulin synthesis in an astrocyte subpopulation. Journal of Neurochemistry 1987; 49: 1139
   Google Scholar
• Cooperman B. S., Stavridi E., Nickbarg E., Rescorla E., Schechter N. M., Rubin H. Antichymotrypsin interaction with chymotrypsin. Partitioning of the complex. J. Biol. Chem. 1993; 268(23)616
   Google Scholar
• Laug W. E., Aebersold R., Jong A., Rideout W., Bergman B. L., Baker J. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. Thromb. Haem. 1989; 62: 517
   Google Scholar
• Shieh B. H., Potempa J., Travis J. The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins. J. Biol. Chem. 1989; 264(13)420
   Google Scholar
• Lawson J. H., Butenas S., Ribarik N., Mann K. G. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J. Biol. Chem. 1993; 268: 767
   PubMed Web of Science ®Google Scholar
• Tollefsen D. M. The interaction of gly-cosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide. Adv. Exp. Med. Biol. 1992; 313: 167
   Google Scholar
• Knupp C. L. The interaction of thrombin with platelet protease nexin. Throm. Res. 1989; 56: 77
   Google Scholar